| Literature DB >> 29704665 |
Vanessa L Hale1, Patricio Jeraldo2, Michael Mundy3, Janet Yao4, Gary Keeney5, Nancy Scott5, E Heidi Cheek5, Jennifer Davidson5, Megan Greene5, Christine Martinez5, John Lehman5, Chandra Pettry5, Erica Reed5, Kelly Lyke6, Bryan A White7, Christian Diener8, Osbaldo Resendis-Antonio9, Jaime Gransee10, Tumpa Dutta10, Xuan-Mai Petterson10, Lisa Boardman11, David Larson6, Heidi Nelson2, Nicholas Chia12.
Abstract
Multi-omic data and genome-scale microbial metabolic models have allowed us to examine microbial communities, community function, and interactions in ways that were not available to us historically. Now, one of our biggest challenges is determining how to integrate data and maximize data potential. Our study demonstrates one way in which to test a hypothesis by combining multi-omic data and community metabolic models. Specifically, we assess hydrogen sulfide production in colorectal cancer based on stool, mucosa, and tissue samples collected on and off the tumor site within the same individuals. 16S rRNA microbial community and abundance data were used to select and inform the metabolic models. We then used MICOM, an open source platform, to track the metabolic flux of hydrogen sulfide through a defined microbial community that either represented on-tumor or off-tumor sample communities. We also performed targeted and untargeted metabolomics, and used the former to quantitatively evaluate our model predictions. A deeper look at the models identified several unexpected but feasible reactions, microbes, and microbial interactions involved in hydrogen sulfide production for which our 16S and metabolomic data could not account. These results will guide future in vitro, in vivo, and in silico tests to establish why hydrogen sulfide production is increased in tumor tissue.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29704665 PMCID: PMC6191348 DOI: 10.1016/j.ymeth.2018.04.024
Source DB: PubMed Journal: Methods ISSN: 1046-2023 Impact factor: 3.608